There are 398 resources available
164O - Health-Related Quality of Life (HRQoL) With Pembrolizumab (pembro) + Chemotherapy (chemo) vs Placebo (pbo) + Chemo as 1L Treatment for Advanced Triple-Negative Breast Cancer (TNBC): Results From KEYNOTE-355
Presenter: David Cescon
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Neo-adjuvant and adjuvant triple negative breast cancer (TNBC)
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Risk based prevention and screening in breast cancer
Resources:
Webcast
Invited Discussant 163O and 164O
Presenter: Ines Vaz Luis
Session: Proffered Paper session 1
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Proffered Paper session 1
Resources:
Webcast
Introduction by the Chairs
Presenter: Giuseppe Curigliano
Session: Keynote lecture: Optimising adjuvant treatment in HR+/HER2 negative early breast cancer
Resources:
Webcast
Optimising adjuvant treatment in HR+/HER2 negative early breast cancer
Presenter: Joseph Sparano
Session: Keynote lecture: Optimising adjuvant treatment in HR+/HER2 negative early breast cancer
Resources:
Slides
Webcast
Biomarkers of immune checkpoint blockade focused on triple negative breast cancer
Presenter: Carsten Denkert
Session: Immunotherapy of metastatic breast cancer: Where do we stand?
Resources:
Slides
Webcast
59MO - Adjuvant Abemaciclib Combined with Endocrine Therapy (ET): Efficacy Results in monarchE Cohort 1
Presenter: Mattea Reinisch
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
Novel combinatorial strategies for enhancing the efficacy of immune checkpoint inhibitors in metastatic breast cancer
Presenter: Marleen Kok
Session: Immunotherapy of metastatic breast cancer: Where do we stand?
Resources:
Slides
Webcast